UBS Boosts Price Target on Abiomed (ABMD) to $28
Tweet Send to a Friend
UBS boosts its price target on Abiomed Inc. (Nasdaq: ABMD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


